NanoViricides, Inc.
NNVC · AMEX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.22 | 0.49 | -0.27 | 0.20 |
| FCF Yield | -40.33% | -29.47% | -43.54% | -28.66% |
| EV / EBITDA | -2.25 | -2.29 | -0.67 | -1.05 |
| Quality | ||||
| ROIC | -127.59% | -74.29% | -54.65% | -35.01% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.90 | 0.76 | 0.66 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -31.88% | -11.17% | 6.34% | 26.47% |
| Safety | ||||
| Net Debt / EBITDA | 0.18 | 0.64 | 1.04 | 1.89 |
| Interest Coverage | -0.06 | -170.98 | -9,534.61 | -1,583.76 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -628.39 | -180.94 | 0.00 | 0.00 |